Regulations.gov document
Male Breast Cancer: Developing Drugs for Treatment; Guidance for Industry; Availability
Notice · FDA-2019-D-2966 · posted Aug 12, 2020
Key facts
| Document ID | FDA-2019-D-2966-0025 |
|---|---|
| Title | Male Breast Cancer: Developing Drugs for Treatment; Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2019-D-2966 |
| Posted | Aug 12, 2020 |
| Federal Register citation | 85 FR 48706 |
| FR document number | 2020-17575 |
| Comment period opens | Aug 12, 2020 |
| Effective date | Aug 12, 2020 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: